Synopsys, Inc. $SNPS Stock: M&G PLC Reduces Holdings

M&G PLC cut its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 4.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 419,869 shares of the semiconductor company’s stock after selling 19,819 shares during the quarter. M&G PLC’s holdings in Synopsys were worth $182,643,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Elevation Wealth Partners LLC grew its holdings in Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the period. North Dakota State Investment Board raised its holdings in shares of Synopsys by 0.5% during the third quarter. North Dakota State Investment Board now owns 5,706 shares of the semiconductor company’s stock valued at $2,482,000 after purchasing an additional 29 shares during the period. Oak Grove Capital LLC raised its holdings in shares of Synopsys by 1.1% during the third quarter. Oak Grove Capital LLC now owns 2,898 shares of the semiconductor company’s stock valued at $1,260,000 after purchasing an additional 32 shares during the period. Kintegral Advisory LLC boosted its position in shares of Synopsys by 0.6% during the 3rd quarter. Kintegral Advisory LLC now owns 5,812 shares of the semiconductor company’s stock worth $2,528,000 after purchasing an additional 32 shares in the last quarter. Finally, Centaurus Financial Inc. boosted its position in shares of Synopsys by 2.6% during the 1st quarter. Centaurus Financial Inc. now owns 1,434 shares of the semiconductor company’s stock worth $569,000 after purchasing an additional 36 shares in the last quarter. 85.47% of the stock is owned by institutional investors.

Insider Buying and Selling at Synopsys

In other Synopsys news, CEO Sassine Ghazi sold 14,604 shares of the business’s stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the completion of the sale, the chief executive officer directly owned 76,865 shares of the company’s stock, valued at approximately $28,815,151.20. The trade was a 15.97% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Aart de Geus sold 25,000 shares of the stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $441.76, for a total value of $11,044,000.00. Following the completion of the sale, the insider directly owned 120,421 shares of the company’s stock, valued at approximately $53,197,180.96. This trade represents a 17.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 117,163 shares of company stock worth $51,366,457 in the last quarter. 0.56% of the stock is owned by insiders.

Analysts Set New Price Targets

Several analysts have recently commented on SNPS shares. Barclays started coverage on Synopsys in a research note on Friday, September 25th. They issued an “overweight” rating for the company. Roth Capital raised Synopsys to a “buy” rating in a research note on Friday, September 25th. HSBC downgraded Synopsys from a “buy” rating to a “reduce” rating in a research note on Friday, September 25th. BNP Paribas Exane increased their price target on Synopsys from $420.00 to $475.00 and gave the stock a “neutral” rating in a report on Thursday, October 1st. Finally, JPMorgan Chase & Co. reduced their price objective on Synopsys from $650.00 to $600.00 in a research note on Thursday, August 27th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Synopsys presently has a consensus rating of “Moderate Buy” and an average target price of $575.00.

Synopsys Stock Performance

SNPS opened at $466.97 on Tuesday. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The company’s fifty day moving average price is $442.10 and its two-hundred day moving average price is $442.00. Synopsys, Inc. has a 1-year low of $362.55 and a 1-year high of $539.48. The company has a market cap of $89.49 billion, a price-to-earnings ratio of 82.50, a PEG ratio of 1.47 and a beta of 1.18.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion during the quarter, compared to analysts’ expectations of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The business’s revenue was up 42.4% on a year-over-year basis. During the same period last year, the company earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, analysts expect that Synopsys, Inc. will post 11.01 EPS for the current fiscal year.

Synopsys announced that its Board of Directors has initiated a stock buyback program on Monday, October 5th that authorizes the company to repurchase $1 billion in outstanding shares. This buyback authorization authorizes the semiconductor company to repurchase up to 1.1% of its shares through open market purchases. Stock buyback programs are often an indication that the company’s board of directors believes its shares are undervalued.

Synopsys Profile

Synopsys, Inc develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs.

The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.